Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)

NCT02914886 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes
Lipoatrophy

Interventions

DRUG: Apidra
DRUG: current insulin

Sponsor

Kinderkrankenhaus auf der Bult

Collaborators

[object Object]